Catalysts
Catalysts — Gopal Snacks Limited (GOPAL)
Catalyst Setup
The next six months hinge on FY2026 audited results on 12 May 2026 and the Q1 FY27 print in August 2026 — the first two reports where supply-chain normalisation can actually show up in margins. The catalyst calendar is concentrated, not thin: five hard-dated events sit inside the next 180 days, and the single highest‑impact one is the FY2026 earnings call, where management must either credibly reaffirm its FY2027 EBITDA target of 8–9 % or lose the last institutional believers.
Hard‑Dated Events (Next 6 Months)
High‑Impact Catalysts
Next Hard Date (Days)
Signal Quality (1‑5)
Signal quality is 3 out of 5 — events are verifiable and imminent, but management’s forecasting record dilutes the information content of its own guidance. The market will judge Gopal on reported numbers, not management promises.
Ranked Catalyst Timeline
Calendar quality: Concentrated. Five hard‑dated events inside six months, with the two earnings reports carrying the highest decision value. The calendar is far from thin — but only the FY2026 results (12 May) and Q1 FY27 results (Jul‑Aug) are likely to change underwriting.
Impact Matrix
Binder Error: Could not ORDER BY column "rank": add the expression/function to every SELECT, or move the UNION into a FROM clause.
Next 90 Days
12 May 2026 — FY2026 Audited Results: The most acute catalyst. Markets will watch for (a) actual FY2026 revenue closing (expect ~₹1,500 Cr, roughly flat Y‑o‑Y), (b) Q4 FY2026 EBITDA margin trajectory (Q3 was 7.6 %, need to see 8 %+ exit rate), and (c) management’s stated FY2027 revenue and margin guidance. A Q4 gross margin above 27 % and EBITDA margin above 8 % would be the first credible signal that the recovery is real. Any guidance revision below ₹1,750 Cr would be received as a broken promise — the fourth in two years.
May‑June 2026 — Rajkot Plant Partial Restart: Management guided for “last week of March or mid‑April 2026”. The actual restart date matters less than its reflection in Q1 FY27 volumes. Watch whether the restart is announced before the FY2026 results call — or delayed again. A timely restart reduces the risk that Modasa alone cannot meet festive‑season demand in Q2 FY27.
Continuous — Monthly Revenue Run‑Rate: Q3 FY2026 delivered ₹401 Cr, the highest post‑fire quarter. Management stated November 2025 was the first month to cross the prior‑year comparable. Watch for any indication that December‑January‑February run rates sustained above ₹130 Cr/month. This is the quiet signal that the business is healing before the hard numbers arrive.
The first real catalyst beyond 90 days is Q1 FY2027 results in July‑August 2026 — the first quarter where both Modasa and the partially‑restarted Rajkot plant operate for a full reporting period.
What Would Change the View
Two numbers will dominate the investment debate over the next six months: the FY2026 exit EBITDA margin and the sequential revenue trajectory into Q1 FY2027. If the FY2026 full‑year EBITDA margin lands above 7.5 % and management can project at least 9 % for FY2027 with a straight face — backed by a month‑on‑month revenue run‑rate above ₹400 Cr — the Bull thesis of hidden normalised earnings power becomes investable, and the stock should rerate from >800× TTM P/E toward a forward multiple of 30‑35× on FY2027 estimates. The bear case requires only that margins stay lethargic — if Q1 FY2027 EBITDA margin is below 8 % despite Modasa and Rajkot both running, the operating‑leverage story collapses, the market loses patience, and the stock becomes a value trap at any price. The insurance settlement and promoter‑shareholding compliance are second‑order events that can amplify either outcome but are unlikely to resolve the debate alone.